Related references
Note: Only part of the references are listed.Rationale and design of ApoA-I Event Reducing in Ischemic Syndromes II (AEGIS-II): A phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of CSL112 in subjects after acute myocardial infarction
C. Michael Gibson et al.
AMERICAN HEART JOURNAL (2021)
Exploring the therapeutic potential of the bioinspired reconstituted high density lipoprotein nanostructures
Aditya Gupta et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)
Effect of apoA-I PEGylation on the Biological Fate of Biomimetic High-Density Lipoproteins
Dennis Pedersbaek et al.
ACS OMEGA (2021)
Phospholipid Component Defines Pharmacokinetic and Pharmacodynamic Properties of Synthetic High-Density Lipoproteins
Maria Fawaz et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2020)
Cyclodextrin polymer improves atherosclerosis therapy and reduces ototoxicity
Heegon Kim et al.
JOURNAL OF CONTROLLED RELEASE (2020)
High density lipoprotein mimicking nanoparticles for atherosclerosis
Jun Chen et al.
NANO CONVERGENCE (2020)
Reconfiguring Nature's Cholesterol Accepting Lipoproteins as Nanoparticle Platforms for Transport and Delivery of Therapeutic and Imaging Agents
Skylar T. Chuang et al.
NANOMATERIALS (2020)
No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levels
Kang H. Zheng et al.
ATHEROSCLEROSIS (2020)
High Density Lipoproteins: Metabolism, Function, and Therapeutic Potential
Anne Jomard et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2020)
Supramolecular Assembly of High-Density Lipoprotein Mimetic Nanoparticles Using Lipid-Conjugated Core Scaffolds
Stephen E. Henrich et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)
Artificial High Density Lipoprotein Nanoparticles in Cardiovascular Research
Karin Kornmueller et al.
MOLECULES (2019)
Proceedings of the Ninth HDL (High-Density Lipoprotein) Workshop Focus on Cardiovascular Disease
Annabelle Rodriguez et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
Anti-Inflammatory Effects of HDL (High-Density Lipoprotein) in Macrophages Predominate Over Proinflammatory Effects in Atherosclerotic Plaques
Panagiotis Fotakis et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
Effects of high-density lipoprotein targeting treatments on cardiovascular outcomes: A systematic review and meta-analysis
Haris Riaz et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2019)
Hydroxyapatite-binding micelles for the detection of vascular calcification in atherosclerosis
Deborah D. Chin et al.
JOURNAL OF MATERIALS CHEMISTRY B (2019)
Effect of Synthetic High Density Lipoproteins Modification with Polyethylene Glycol on Pharmacokinetics and Pharmacodynamics
Dan Li et al.
MOLECULAR PHARMACEUTICS (2018)
CSL112 (Apolipoprotein A-I [Human]) Enhances Cholesterol Efflux Similarly in Healthy Individuals and Stable Atherosclerotic Disease Patients
Andreas Gille et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2018)
From High-Density Lipoprotein Cholesterol to Measurements of Function: Prospects for the Development of Tests for High-Density Lipoprotein Functionality in Cardiovascular Disease
Frank M. Sacks et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2018)
HDL Mimetics Infusion and Regression of Atherosclerosis: Is It Still Considered a Valid Therapeutic Option?
I. Karalis et al.
CURRENT CARDIOLOGY REPORTS (2018)
Micelles with ultralow critical micelle concentration as carriers for drug delivery
Yang Lu et al.
NATURE BIOMEDICAL ENGINEERING (2018)
Translating Evidence of HDL and Plaque Regression
Belinda A. Di Bartolo et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2018)
Core hydrophobicity tuning of a self-assembled particle results in efficient lipid reduction and favorable organ distribution
Bhabatosh Banik et al.
NANOSCALE (2018)
Apolipoprotein A-I Infusion Therapies for Coronary Disease Two Outs in the Ninth Inning and Swinging for the Fences
Daniel J. Rader
JAMA CARDIOLOGY (2018)
Effect of Serial Infusions of CER-001, a Pre-β High-Density Lipoprotein Mimetic, on Coronary Atherosclerosis in Patients Following Acute Coronary Syndromes in the CER-001 Atherosclerosis Regression Acute Coronary Syndrome Trial A Randomized Clinical Trial
Stephen J. Nicholls et al.
JAMA CARDIOLOGY (2018)
Effect of Infusion of High-Density Lipoprotein Mimetic Containing Recombinant Apolipoprotein A-I Milano on Coronary Disease in Patients With an Acute Coronary Syndrome in the MILANO-PILOT Trial A Randomized Clinical Trial
Stephen J. Nicholls et al.
JAMA CARDIOLOGY (2018)
Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease: Results From the Cooper Center Longitudinal Study
Shuaib M. Abdullah et al.
CIRCULATION (2018)
Applications of Noble Metal-Based Nanoparticles in Medicine
Bartosz Klebowski et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Intravenous toxicity and toxicokinetics of an HDL mimetic, Fx-5A peptide complex, in cynomolgus monkeys
Mohammed Bourdi et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2018)
Antioxidative activity of high-density lipoprotein (HDL): Mechanistic insights into potential clinical benefit
Fernando Brites et al.
BBA CLINICAL (2017)
Apolipoprotein A-I Mimetic Peptides Discordance Between In Vitro and In Vivo Properties-Brief Report
Michael Ditiatkovski et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2017)
Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin)
Amit V. Khera et al.
CIRCULATION (2017)
Effect of serial infusions of reconstituted high-density lipoprotein (CER-001) on coronary atherosclerosis: rationale and design of the CARAT study
Jordan Andrews et al.
CARDIOVASCULAR DIAGNOSIS AND THERAPY (2017)
Molecular Dynamics Simulation and Experimental Studies of Gold Nanoparticle Templated HDL-like Nanoparticles for Cholesterol Metabolism Therapeutics
Cheng-Tsung Lai et al.
ACS APPLIED MATERIALS & INTERFACES (2017)
High-Density Lipoproteins: Nature's Multifunctional Nanoparticles
Rui Kuai et al.
ACS NANO (2016)
High-Density Lipoprotein Infusion Therapy and Atherosclerosis Current Research and Future Directions
Nan Chen et al.
CARDIOLOGY IN REVIEW (2016)
Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial Infarction The AEGIS-I Trial (ApoA-I Event Reducing in Ischemic Syndromes I)
C. Michael Gibson et al.
CIRCULATION (2016)
Randomized double blind clinical trial on the effect of oral α-cyclodextrin on serum lipids
Marcelo J. A. Amar et al.
LIPIDS IN HEALTH AND DISEASE (2016)
Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming
Sebastian Zimmer et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
HDL-Mimetic PLGA Nanoparticle To Target Atherosclerosis Plaque Macrophages
Brenda L. Sanchez-Gaytan et al.
BIOCONJUGATE CHEMISTRY (2015)
The effect of phospholipid composition of reconstituted HDL on its cholesterol efflux and anti-inflammatory properties
Anna Schwendeman et al.
JOURNAL OF LIPID RESEARCH (2015)
Effect of open-label infusion of an apoA-I-containing particle (CER-001) on RCT and artery wall thickness in patients with FHA
Ruud S. Kootte et al.
JOURNAL OF LIPID RESEARCH (2015)
Intracisternal cyclodextrin prevents cerebellar dysfunction and Purkinje cell death in feline Niemann-Pick type C1 disease
Charles H. Vite et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Infusion of Reconstituted High-Density Lipoprotein, CSL112, in Patients With Atherosclerosis: Safety and Pharmacokinetic Results From a Phase 2a Randomized Clinical Trial
Pierluigi Tricoci et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2015)
High-Density Lipoprotein Vascular Protective Effects, Dysfunction, and Potential as Therapeutic Target
Thomas F. Luescher et al.
CIRCULATION RESEARCH (2014)
The Combined Therapeutical Effect of Metal-based Drugs and Radiation Therapy: The Present Status of Research
C. Ceresa et al.
CURRENT MEDICINAL CHEMISTRY (2014)
Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial
Jean-Claude Tardif et al.
EUROPEAN HEART JOURNAL (2014)
In vivo efficacy of HDL-like nanolipid particles containing multivalent peptide mimetics of apolipoprotein A-I
Yannan Zhao et al.
JOURNAL OF LIPID RESEARCH (2014)
Molecules That Mimic Apolipoprotein A-I: Potential Agents for Treating Atherosclerosis
Luke J. Leman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Future of High-Density Lipoprotein Infusion Therapies: Potential for Clinical Management of Vascular Disease
Bronwyn A. Kingwell et al.
CIRCULATION (2013)
Pegylation of High-Density Lipoprotein Decreases Plasma Clearance and Enhances Antiatherogenic Activity
Andrew J. Murphy et al.
CIRCULATION RESEARCH (2013)
Biodegradable synthetic high-density lipoprotein nanoparticles for atherosclerosis
Sean Marrache et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
High-Density Lipoprotein Function, Dysfunction, and Reverse Cholesterol Transport
Edward A. Fisher et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Role of plasma phospholipid transfer protein in lipid and lipoprotein metabolism
John J. Albers et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2012)
The not-so-simple HDL story Is it time to revise the HDL cholesterol hypothesis?
Daniel J. Rader et al.
NATURE MEDICINE (2012)
The apolipoprotein A-I mimetic peptide ETC-642 exhibits anti-inflammatory properties that are comparable to high density lipoproteins
Belinda A. Di Bartolo et al.
ATHEROSCLEROSIS (2011)
Treatment of patients with cardiovascular disease with L-4F, an apo-A1 mimetic, did not improve select biomarkers of HDL function
Catherine E. Watson et al.
JOURNAL OF LIPID RESEARCH (2011)
The apolipoprotein A-I mimetic peptide, ETC-642, reduces chronic vascular inflammation in the rabbit
Belinda A. Di Bartolo et al.
LIPIDS IN HEALTH AND DISEASE (2011)
Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size
H. Cabral et al.
NATURE NANOTECHNOLOGY (2011)
The 5A Apolipoprotein A-I Mimetic Peptide Displays Antiinflammatory and Antioxidant Properties In Vivo and In Vitro
Fatiha Tabet et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Emerging high-density lipoprotein infusion therapies: Fulfilling the promise of epidemiology?
Jean-Claude Tardif
JOURNAL OF CLINICAL LIPIDOLOGY (2010)
A First-in-Man, Randomized, Placebo-Controlled Study to Evaluate the Safety and Feasibility of Autologous Delipidated High-Density Lipoprotein Plasma Infusions in Patients With Acute Coronary Syndrome
Ron Waksman et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Endocytosis of beta-cyclodextrins is responsible for cholesterol reduction in Niemann-Pick type C mutant cells
Anton I. Rosenbaum et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Atherosclerotic Plaque Composition: Analysis with Multicolor CT and Targeted Gold Nanoparticles
David P. Cormode et al.
RADIOLOGY (2010)
Templated Spherical High Density Lipoprotein Nanoparticles
C. Shad Thaxton et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Targeting atherosclerosis by using modular, multifunctional micelles
David Peters et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Infusion of Reconstituted High-Density Lipoprotein Leads to Acute Changes in Human Atherosclerotic Plaque
James A. Shaw et al.
CIRCULATION RESEARCH (2008)
Nanocrystal Core High-Density Lipoproteins: A Multimodality Contrast Agent Platform
David P. Cormode et al.
NANO LETTERS (2008)
Cellular cholesterol trafficking and compartmentalization
Elina Ikonen
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
High-density lipoprotein as a therapeutic target - A systematic review
Inder M. Singh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis -: A randomized controlled trial
Jean-Claude Tardif et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
D-4F induces heme oxygenase-1 and extracellular superoxide dismutase, decreases endothelial cell sloughing, and improves vascular reactivity in rat model of diabetes
AL Kruger et al.
CIRCULATION (2005)
Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes - A randomized controlled trial
SE Nissen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Hepatic lipase and dyslipidemia: interactions among genetic variants, obesity, gender, and diet
SS Deeb et al.
JOURNAL OF LIPID RESEARCH (2003)
L-4F, an apolipoprotein A-1 mimetic, dramatically improves vasodilation in hypercholesterolemia and sickle cell disease
JS Ou et al.
CIRCULATION (2003)
Share Paper
